Direct-to-consumer pharmaceutical advertising is under increasing political pressure, with bipartisan legislation being introduced to ban or restrict the practice, and states considering bills to deny tax deductions for pharmaceutical advertising expenses.
Politics
·
Is this the end of costly and harmful pharmaceutical advertising?
CN
CitrixNews Staff
Originally reported by The Hill
Related Articles
Politics
Meta Says Israeli Spyware Firm NSO Group Targeted WhatsApp Users Again
The uncovered hacking attempts on the messaging service were linked to NSO Group and may violate a federal court prohibi...
CitrixNews Staff
·
53 minutes ago
Politics
Judge tosses Trump bid to restrict renewable energy tax credits
A federal judge over the weekend struck down a Trump administration effort to restrict tax credits for wind and sol...
CitrixNews Staff
·
59 minutes ago
Politics
Judge Throws Out Policy Imposing $100,000 Fees for Skilled Worker Visas
The ruling voided “in its entirety” a policy from September requiring companies to pay $100,000 fees for H1-B visa petit...
CitrixNews Staff
·
1 hour ago
Politics
Pratt: Hundreds of thousands of votes still outstanding in LA mayor election
Republican Spencer Pratt said Monday that “hundreds of thousands of votes” remain outstanding in the Los Angeles mayoral...
CitrixNews Staff
·
1 hour ago